Cite
APA Citation
Noro, R., Honda, K., Nagashima, K., Motoi, N., Kunugi, S., Matsubayashi, J., Takeuchi, S., Shiraishi, H., Okano, T., Kashiro, A., Meng, X., Yoshida, Y., Watanabe, S., Usuda, J., Inoue, T., Wilber, H., Ikeda, N., Seike, M., Gemma, A., & Kubota, K. (2022). alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas. Cancer science, 113(3), 1002–1009. http://access.bl.uk/ark:/81055/vdc_100152627385.0x000031